Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ZBED9 antisense RNA 1 (ZBED9-AS1)
- Target
- ZBED9-AS1
- Molecular classification
- Long non-coding RNA (lncRNA), Antisense RNA, Other (does not fit into protein-coding categories like enzyme, receptor, transporter, etc.)
01
Overview
ZBED9 antisense RNA 1 (ZBED9-AS1) is a long non-coding antisense RNA gene transcribed from the 6p22.1 region opposite to (i.e., antisense to) the protein-coding zinc finger BED-type containing 9 (ZBED9) gene[3][7]. There is currently no direct functional or mechanistic evaluation of ZBED9-AS1 described in the published literature. By analogy with other antisense lncRNAs, it may be involved in the regulation of expression of the adjacent ZBED9 gene via transcriptional interference, splicing regulation, mRNA stability, or epigenetic mechanisms, but no such specific functions have been demonstrated for ZBED9-AS1 as of the latest available research[3][7][1][2]. It does not encode a protein, does not function as a classical receptor, enzyme, or drug target, and is not directly associated with disease or therapeutic intervention.
- Other names
- ZBED9-AS1ZBED9 antisense RNA 1
02
Mechanism of action
Not applicable. No known drugs or drug-like molecules target ZBED9-AS1, and its mechanism is not characterized.
03
Biological functions
Regulation of gene expression (primarily of the ZBED9 locus, if any; direct evidence lacking for ZBED9-AS1, but consistent with antisense lncRNA functions)Possible influence on transcription, splicing, or mRNA stability of coding genes in the same locus
04
Disease associations
Cancer (general antisense lncRNAs are implicated in oncogenesis and regulation of cancer pathways, but no data shows a cancer role for ZBED9-AS1)Other: potential involvement in epigenetic regulation, based on lncRNA properties
Beyond the preview
Go deeper on ZBED9 antisense RNA 1 (ZBED9-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ZBED9 antisense RNA 1 (ZBED9-AS1).